×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

France Biopsy Devices Market

ID: MRFR/HC/54676-HCR
200 Pages
MRFR Team
February 2026

France Biopsy Devices Market Research Report: By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others) andBy End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

France Biopsy Devices Market Summary

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Industry Developments

Recent developments in the France Biopsy Devices Market include ongoing innovations and advancements from leading companies such as BD, Abbott, and Hologic. Notably, Abbott has recently showcased new biopsy techniques at industry conferences, emphasizing their commitment to improving diagnostic accuracy. In terms of market activity, Medtronic has reported substantial growth in its biopsy segment due to the rising demand for minimally invasive procedures, a trend that continues to enhance overall market valuation. Additionally, there were reports of Bard Peripheral Vascular expanding its product lineup to include more advanced imaging technologies alongside biopsy devices to facilitate better clinical outcomes. As for mergers and acquisitions, in March 2023, Boston Scientific announced its acquisition of a prominent French medical device company, solidifying its footprint in the European market and enhancing its biopsy portfolio. This strategic acquisition is expected to drive further innovation and customer outreach in France, particularly in the oncology sector. Over the past few years, the French government has also increased funding towards medical technologies, with a focus on expanding the adoption of biopsy devices among healthcare facilities, which is influencing market dynamics positively.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 2018118.8(USD Million)
MARKET SIZE 2024126.45(USD Million)
MARKET SIZE 2035295.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 8.005% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDBD, Abbott, Bard Peripheral Vascular, Philips Healthcare, Medtronic, Stryker, Thermo Fisher Scientific, Hologic, Ethicon, Getinge, Elekta, F. HoffmannLa Roche, Boston Scientific, Siemens Healthineers, Cook Medical
SEGMENTS COVEREDProduct Type, Application, Guidance, End User
KEY MARKET OPPORTUNITIESIncreasing cancer prevalence, Technological advancements in devices, Growing demand for minimally invasive procedures, Rising investments in healthcare infrastructure, Expanding applications in diagnostics
KEY MARKET DYNAMICStechnological advancements, increasing cancer prevalence, rising healthcare expenditure, strong R&D initiatives, growing emphasis on minimally invasive procedures
COUNTRIES COVEREDFrance
Leave a Comment

FAQs

What is the current market size of the France Biopsy Devices Market in 2024?

The France Biopsy Devices Market is expected to be valued at 126.45 million USD in 2024.

What is the projected market size of the France Biopsy Devices Market by 2035?

By 2035, the France Biopsy Devices Market is projected to reach a value of 295 million USD.

What is the expected CAGR for the France Biopsy Devices Market from 2025 to 2035?

The expected compound annual growth rate (CAGR) for the France Biopsy Devices Market from 2025 to 2035 is 8.005%.

Which product segment is anticipated to dominate the France Biopsy Devices Market?

Biopsy Needles are anticipated to dominate the France Biopsy Devices Market.

What is the market value of Biopsy Guns in 2024?

In 2024, the market value of Biopsy Guns is expected to be 30 million USD.

What is the market growth rate for Biopsy Guidance Systems from 2024 to 2035?

The market growth for Biopsy Guidance Systems is expected to increase from 25 million USD in 2024 to 60 million USD in 2035.

Who are the key players in the France Biopsy Devices Market?

Key players in the France Biopsy Devices Market include BD, Abbott, and Medtronic, among others.

How much is the market for Localization Wires expected to grow by 2035?

The market for Localization Wires is projected to grow from 11.45 million USD in 2024 to 15 million USD in 2035.

What challenges are expected to affect the growth of the France Biopsy Devices Market?

Challenges such as regulatory hurdles and high costs of advanced devices may affect market growth.

What opportunities exist in the France Biopsy Devices Market beyond 2025?

Innovative technologies and an increasing demand for minimally invasive procedures present significant opportunities in the market.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions